Fig. 2.
Fig. 2. Enhancement of the catalytic inhibition of topo II by hydroquinone; 4,4′-biphenol; and catechol following peroxidase activation. / The pBR322 plasmid DNA (300 ng) was combined with topo II (6 U) following a 10-minute incubation with activated compound (1, 10, 30, 100, 300 μM) in the absence or presence of 100 μM etoposide. (A) DNA cleavage assay performed with peroxidase-activated hydroquinone. (B) DNA cleavage assay performed with peroxidase-activated 4,4′-biphenol. (C) DNA cleavage assay performed with peroxidase-activated catechol. All samples, including untreated controls, contain identical concentrations of activating agents. Reactions were interpreted as described in Figure 1.

Enhancement of the catalytic inhibition of topo II by hydroquinone; 4,4′-biphenol; and catechol following peroxidase activation.

The pBR322 plasmid DNA (300 ng) was combined with topo II (6 U) following a 10-minute incubation with activated compound (1, 10, 30, 100, 300 μM) in the absence or presence of 100 μM etoposide. (A) DNA cleavage assay performed with peroxidase-activated hydroquinone. (B) DNA cleavage assay performed with peroxidase-activated 4,4′-biphenol. (C) DNA cleavage assay performed with peroxidase-activated catechol. All samples, including untreated controls, contain identical concentrations of activating agents. Reactions were interpreted as described in Figure 1.

Close Modal

or Create an Account

Close Modal
Close Modal